DRKS00011674已完成不适用
Impact of intestinal microbiome on infections, course and outcome of haematological-oncological patients treated with chemotherapy - MicroIntest
niversitätsklinikum Magdeburg0 个研究点目标入组 12 人开始时间: 2017年2月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1.Age =18 years;
- •2.Written informed consent;
- •3.AML first diagnose;
- •4.Therapy with repetitive chemotherapy cycles, inclusive allogeneic or autologous stem cell transplantation
排除标准
- •1.Antibiotic therapy =4 weeks before study inclusion;
- •2.AML teatment with cytoreductive long-term therapy (e. g. hydroxyurea);
- •3.Stool transplantation (e. g. due to relapsed C. difficile infection)
研究者
相似试验
暂停
不适用
Influence of the intestinal microbiome on the risk of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosisK65K74.6Other and unspecified cirrhosis of liverPeritonitisDRKS00026834Klinik und Poliklinik für Innere Medizin II Klinikum rechts der Isar der TU München120
已完成
不适用
The role of the intestinal microbiome in enteric and systemic vaccine immune responsesvaccin immunogeniciteitimmunityrotavirus vaccine1001796610047438NL-OMON44814Academisch Medisch Centrum63
已完成
不适用
The influence of the intestinal microbiome on the development of postoperative complications after elective colon surgery - a prospective cohort studyK91.83T79.3Post-traumatic wound infection, not elsewhere classifiedDRKS00014059niversitätsklinikum FreiburgInstitut für Umweltmedizin und KrankenhaushygieneUni-Zentrum Naturheilkunde127
已完成
不适用
Modulation of the intestinal microbiome, and its effects on endurance exercise capacity in moderately trained individualsNL-OMON49125niversiteit Maastricht34
招募中
3 期
Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network StudyPrimary Sclerosing CholangitisACTRN12621000792820Princess Alexandra Hospital34